Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1b, Randomized, Controlled, Double-blind Trial To Evaluate The Safety And Immunogenicity Of Multivalent Pneumococcal Conjugate Vaccines In Healthy Japanese Adults 18 To 49 Years Of Age

Trial Profile

A Phase 1b, Randomized, Controlled, Double-blind Trial To Evaluate The Safety And Immunogenicity Of Multivalent Pneumococcal Conjugate Vaccines In Healthy Japanese Adults 18 To 49 Years Of Age

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 15 Oct 2018

At a glance

  • Drugs Pneumococcal vaccine conjugate (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate
  • Indications Pneumococcal infections
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 08 Oct 2018 Planned End Date changed from 24 Apr 2019 to 25 Mar 2019.
    • 08 Oct 2018 Planned primary completion date changed from 24 Apr 2019 to 25 Mar 2019.
    • 08 Oct 2018 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top